Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 2/2012

01.03.2012 | Original Paper

General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia

verfasst von: János M. Réthelyi, Pál Czobor, Patrícia Polgár, Beatrix Mersich, Sára Bálint, Éva Jekkel, Krisztina Magyar, Ágnes Mészáros, Ágnes Fábián, István Bitter

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Earlier studies suggested more severe overall cognitive impairments in deficit versus non-deficit schizophrenia; however, the specific contribution of different cognitive domains to this overall cognitive impairment remains unclear. The purpose of this study was to compare the two subtypes in general cognitive functioning as well as in individual cognitive domains using the composite score approach. One hundred and forty-three patients fulfilling the criteria for the deficit syndrome were compared with 123 patients diagnosed with non-deficit schizophrenia. Neurocognitive functioning was assessed by a neuropsychological test battery measuring the domains of sustained vigilance/attention, working memory, short-term memory, verbal memory, cognitive flexibility, and ideation fluency. Using the raw neuropsychological measures, we calculated a global index of cognitive impairment and domain-specific composite z-scores. Association between these composite scores and the deficit syndrome was examined by logistic regression analysis. After adjusting for relevant covariates including sex, age, education, smoking, and antipsychotic dose, results indicated a significant increase in the likelihood of deficit syndrome as a function of global (OR = 5.40; 95% CI 3.02–9.65) as well as domain-specific impairments (OR > 2 for all individual domains except for short-term memory). Cognitive flexibility was an independent predictor (OR = 2.92; 95% CI 1.47–5.80), whereas other cognitive domains demonstrated no unique contribution to the general cognitive impairment. Patients with deficit schizophrenia suffer from a more severe degree of neurocognitive impairment, which is qualitatively similar to the dysfunction seen in non-deficit schizophrenia. However, our results indicate that cognitive flexibility is specifically impaired in deficit versus non-deficit patients and may therefore represent a core feature of this subtype.
Literatur
1.
Zurück zum Zitat Carpenter WT Jr, Heinrichs DW, Wagman AM (1988) Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 145:578–583PubMed Carpenter WT Jr, Heinrichs DW, Wagman AM (1988) Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 145:578–583PubMed
2.
Zurück zum Zitat Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT Jr (2001) A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry 58:165–171PubMedCrossRef Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT Jr (2001) A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry 58:165–171PubMedCrossRef
3.
Zurück zum Zitat Galderisi S, Maj M (2009) Deficit schizophrenia: an overview of clinical, biological and treatment aspects. Eur Psychiatry 24:493–500PubMedCrossRef Galderisi S, Maj M (2009) Deficit schizophrenia: an overview of clinical, biological and treatment aspects. Eur Psychiatry 24:493–500PubMedCrossRef
4.
Zurück zum Zitat Green MF (2007) Stimulating the development of drug treatments to improve cognition in schizophrenia. Annu Rev Clin Psychol 3:159–180PubMedCrossRef Green MF (2007) Stimulating the development of drug treatments to improve cognition in schizophrenia. Annu Rev Clin Psychol 3:159–180PubMedCrossRef
5.
Zurück zum Zitat Buchanan RW, Strauss ME, Kirkpatrick B, Holstein C, Breier A, Carpenter WT Jr (1994) Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. Arch Gen Psychiatry 51:804–811PubMedCrossRef Buchanan RW, Strauss ME, Kirkpatrick B, Holstein C, Breier A, Carpenter WT Jr (1994) Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. Arch Gen Psychiatry 51:804–811PubMedCrossRef
6.
Zurück zum Zitat Bryson G, Whelahan HA, Bell M (2001) Memory and executive function impairments in deficit syndrome schizophrenia. Psychiatry Res 102:29–37PubMedCrossRef Bryson G, Whelahan HA, Bell M (2001) Memory and executive function impairments in deficit syndrome schizophrenia. Psychiatry Res 102:29–37PubMedCrossRef
7.
Zurück zum Zitat Brazo P, Marie RM, Halbecq I, Benali K, Segard L, Delamillieure P, Langlois-Thery S, Van Der Elst A, Thibaut F, Petit M, Dollfus S (2002) Cognitive patterns in subtypes of schizophrenia. Eur Psychiatry 17:155–162PubMedCrossRef Brazo P, Marie RM, Halbecq I, Benali K, Segard L, Delamillieure P, Langlois-Thery S, Van Der Elst A, Thibaut F, Petit M, Dollfus S (2002) Cognitive patterns in subtypes of schizophrenia. Eur Psychiatry 17:155–162PubMedCrossRef
8.
Zurück zum Zitat Galderisi S, Maj M, Mucci A, Cassano GB, Invernizzi G, Rossi A, Vita A, Dell’Osso L, Daneluzzo E, Pini S (2002) Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. Am J Psychiatry 159:983–990PubMedCrossRef Galderisi S, Maj M, Mucci A, Cassano GB, Invernizzi G, Rossi A, Vita A, Dell’Osso L, Daneluzzo E, Pini S (2002) Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. Am J Psychiatry 159:983–990PubMedCrossRef
9.
Zurück zum Zitat Cohen AS, Saperstein AM, Gold JM, Kirkpatrick B, Carpenter WT Jr, Buchanan RW (2007) Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Schizophr Bull 33:1201–1212PubMedCrossRef Cohen AS, Saperstein AM, Gold JM, Kirkpatrick B, Carpenter WT Jr, Buchanan RW (2007) Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Schizophr Bull 33:1201–1212PubMedCrossRef
10.
Zurück zum Zitat Jaeger J, Czobor P, Berns SM (2003) Basic neuropsychological dimensions in schizophrenia. Schizophr Res 65:105–116PubMedCrossRef Jaeger J, Czobor P, Berns SM (2003) Basic neuropsychological dimensions in schizophrenia. Schizophr Res 65:105–116PubMedCrossRef
11.
Zurück zum Zitat Bilder RM, Goldman RS, Volavka J, Czobor P, Hoptman M, Sheitman B, Lindenmayer JP, Citrome L, McEvoy J, Kunz M, Chakos M, Cooper TB, Horowitz TL, Lieberman JA (2002) Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 159:1018–1028PubMedCrossRef Bilder RM, Goldman RS, Volavka J, Czobor P, Hoptman M, Sheitman B, Lindenmayer JP, Citrome L, McEvoy J, Kunz M, Chakos M, Cooper TB, Horowitz TL, Lieberman JA (2002) Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 159:1018–1028PubMedCrossRef
12.
Zurück zum Zitat Psychiatric American Association (1994) Diagnostic and statistical manual of mental disorders: DSM-IV. American Psychiatric Association Press, Washington, DC Psychiatric American Association (1994) Diagnostic and statistical manual of mental disorders: DSM-IV. American Psychiatric Association Press, Washington, DC
13.
Zurück zum Zitat Rethelyi JM, Bakker SC, Polgar P, Czobor P, Strengman E, Pasztor PI, Kahn RS, Bitter I (2010) Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. Am J Med Genet B Neuropsychiatr Genet 153B:792–801PubMed Rethelyi JM, Bakker SC, Polgar P, Czobor P, Strengman E, Pasztor PI, Kahn RS, Bitter I (2010) Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. Am J Med Genet B Neuropsychiatr Genet 153B:792–801PubMed
14.
Zurück zum Zitat Balázs J, Bitter I, Hideg K, Vitrai J (1998) The Hungarian version of the M.I.N.I. and the M.I.N.I. Plus (in Hungarian). Psychiatria Hungarica 13:160–168 Balázs J, Bitter I, Hideg K, Vitrai J (1998) The Hungarian version of the M.I.N.I. and the M.I.N.I. Plus (in Hungarian). Psychiatria Hungarica 13:160–168
15.
Zurück zum Zitat Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276PubMed Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276PubMed
16.
Zurück zum Zitat Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT Jr (1989) The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res 30:119–123PubMedCrossRef Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT Jr (1989) The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res 30:119–123PubMedCrossRef
17.
Zurück zum Zitat Baldessarini RJ, Tarazi FI (2001) Drugs and the treatment of psychiatric disorders: antipsychotic and antimaniac agents. In: Hardman JG, Limbird LE, Gilman AG (eds) Goodman and Gilman’s the pharmacological basis of therapeutics. McGraw-Hill, New York, pp 485–520 Baldessarini RJ, Tarazi FI (2001) Drugs and the treatment of psychiatric disorders: antipsychotic and antimaniac agents. In: Hardman JG, Limbird LE, Gilman AG (eds) Goodman and Gilman’s the pharmacological basis of therapeutics. McGraw-Hill, New York, pp 485–520
18.
Zurück zum Zitat Woods SW (2003) Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64:663–667PubMedCrossRef Woods SW (2003) Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64:663–667PubMedCrossRef
19.
Zurück zum Zitat Strauss E, Sherman EMS, Spreen O (2006) A compendium of neuropsychological tests. Administration, norms, and commentary. Oxford University Press, Oxford Strauss E, Sherman EMS, Spreen O (2006) A compendium of neuropsychological tests. Administration, norms, and commentary. Oxford University Press, Oxford
20.
Zurück zum Zitat Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum Associates, Hillsdale, NJ Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum Associates, Hillsdale, NJ
21.
Zurück zum Zitat Owens SF, Rijsdijk F, Picchioni MM, Stahl D, Nenadic I, Murray RM, Toulopoulou T (2011) Genetic overlap between schizophrenia and selective components of executive function. Schizophr Res 127:181–187PubMedCrossRef Owens SF, Rijsdijk F, Picchioni MM, Stahl D, Nenadic I, Murray RM, Toulopoulou T (2011) Genetic overlap between schizophrenia and selective components of executive function. Schizophr Res 127:181–187PubMedCrossRef
22.
Zurück zum Zitat Cascella NG, Testa SM, Meyer SM, Rao VA, Diaz-Asper CM, Pearlson GD, Schretlen DJ (2008) Neuropsychological impairment in deficit vs. non-deficit schizophrenia. J Psychiatr Res 42:930–937PubMedCrossRef Cascella NG, Testa SM, Meyer SM, Rao VA, Diaz-Asper CM, Pearlson GD, Schretlen DJ (2008) Neuropsychological impairment in deficit vs. non-deficit schizophrenia. J Psychiatr Res 42:930–937PubMedCrossRef
23.
Zurück zum Zitat Wang X, Yao S, Kirkpatrick B, Shi C, Yi J (2008) Psychopathology and neuropsychological impairments in deficit and nondeficit schizophrenia of Chinese origin. Psychiatry Res 158:195–205PubMedCrossRef Wang X, Yao S, Kirkpatrick B, Shi C, Yi J (2008) Psychopathology and neuropsychological impairments in deficit and nondeficit schizophrenia of Chinese origin. Psychiatry Res 158:195–205PubMedCrossRef
24.
Zurück zum Zitat Polgar P, Farkas M, Nagy O, Kelemen O, Rethelyi J, Bitter I, Myers CE, Gluck MA, Keri S (2008) How to find the way out from four rooms? The learning of “chaining” associations may shed light on the neuropsychology of the deficit syndrome of schizophrenia. Schizophr Res 99:200–207PubMedCrossRef Polgar P, Farkas M, Nagy O, Kelemen O, Rethelyi J, Bitter I, Myers CE, Gluck MA, Keri S (2008) How to find the way out from four rooms? The learning of “chaining” associations may shed light on the neuropsychology of the deficit syndrome of schizophrenia. Schizophr Res 99:200–207PubMedCrossRef
25.
Zurück zum Zitat Szendi I, Racsmany M, Cimmer C, Csifcsak G, Kovacs ZA, Szekeres G, Galsi G, Toth F, Nagy A, Garab EA, Boda K, Gulyas G, Kiss JG, Dombi J, Pleh C, Janka Z (2010) Two subgroups of schizophrenia identified by systematic cognitive neuropsychiatric mapping. Eur Arch Psychiatry Clin Neurosci 260:257–266PubMedCrossRef Szendi I, Racsmany M, Cimmer C, Csifcsak G, Kovacs ZA, Szekeres G, Galsi G, Toth F, Nagy A, Garab EA, Boda K, Gulyas G, Kiss JG, Dombi J, Pleh C, Janka Z (2010) Two subgroups of schizophrenia identified by systematic cognitive neuropsychiatric mapping. Eur Arch Psychiatry Clin Neurosci 260:257–266PubMedCrossRef
26.
Zurück zum Zitat Dickinson D, Ragland JD, Gold JM, Gur RC (2008) General and specific cognitive deficits in schizophrenia: Goliath defeats David? Biol Psychiatry 64:823–827PubMedCrossRef Dickinson D, Ragland JD, Gold JM, Gur RC (2008) General and specific cognitive deficits in schizophrenia: Goliath defeats David? Biol Psychiatry 64:823–827PubMedCrossRef
27.
Zurück zum Zitat Tuulio-Henriksson A, Perala J, Saarni SI, Isometsa E, Koskinen S, Lonnqvist J, Suvisaari J (2011) Cognitive functioning in severe psychiatric disorders: a general population study. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-010-0186-y Tuulio-Henriksson A, Perala J, Saarni SI, Isometsa E, Koskinen S, Lonnqvist J, Suvisaari J (2011) Cognitive functioning in severe psychiatric disorders: a general population study. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-010-0186-y
28.
Zurück zum Zitat Cascella NG, Fieldstone SC, Rao VA, Pearlson GD, Sawa A, Schretlen DJ (2010) Gray-matter abnormalities in deficit schizophrenia. Schizophr Res 120:63–70PubMedCrossRef Cascella NG, Fieldstone SC, Rao VA, Pearlson GD, Sawa A, Schretlen DJ (2010) Gray-matter abnormalities in deficit schizophrenia. Schizophr Res 120:63–70PubMedCrossRef
29.
Zurück zum Zitat Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, Krishnan-Sarin S, Jatlow PI, Wexler BE, George TP (2005) Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry 62:649–659PubMedCrossRef Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, Krishnan-Sarin S, Jatlow PI, Wexler BE, George TP (2005) Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry 62:649–659PubMedCrossRef
30.
Zurück zum Zitat Segarra R, Zabala A, Eguiluz JI, Ojeda N, Elizagarate E, Sanchez P, Ballesteros J, Gutierrez M (2010) Cognitive performance and smoking in first-episode psychosis: the self-medication hypothesis. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-010-0146-6 Segarra R, Zabala A, Eguiluz JI, Ojeda N, Elizagarate E, Sanchez P, Ballesteros J, Gutierrez M (2010) Cognitive performance and smoking in first-episode psychosis: the self-medication hypothesis. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-010-0146-6
31.
Zurück zum Zitat Hori H, Noguchi H, Hashimoto R, Nakabayashi T, Omori M, Takahashi S, Tsukue R, Anami K, Hirabayashi N, Harada S, Saitoh O, Iwase M, Kajimoto O, Takeda M, Okabe S, Kunugi H (2006) Antipsychotic medication and cognitive function in schizophrenia. Schizophr Res 86:138–146PubMedCrossRef Hori H, Noguchi H, Hashimoto R, Nakabayashi T, Omori M, Takahashi S, Tsukue R, Anami K, Hirabayashi N, Harada S, Saitoh O, Iwase M, Kajimoto O, Takeda M, Okabe S, Kunugi H (2006) Antipsychotic medication and cognitive function in schizophrenia. Schizophr Res 86:138–146PubMedCrossRef
32.
Zurück zum Zitat Elie D, Poirier M, Chianetta J, Durand M, Gregoire C, Grignon S (2010) Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder. J Psychopharmacol 24:1037–1044PubMedCrossRef Elie D, Poirier M, Chianetta J, Durand M, Gregoire C, Grignon S (2010) Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder. J Psychopharmacol 24:1037–1044PubMedCrossRef
33.
Zurück zum Zitat Malaspina D, Coleman E (2003) Olfaction and social drive in schizophrenia. Arch Gen Psychiatry 60:578–584PubMedCrossRef Malaspina D, Coleman E (2003) Olfaction and social drive in schizophrenia. Arch Gen Psychiatry 60:578–584PubMedCrossRef
34.
Zurück zum Zitat Horan WP, Blanchard JJ (2003) Neurocognitive, social, and emotional dysfunction in deficit syndrome schizophrenia. Schizophr Res 65:125–137PubMedCrossRef Horan WP, Blanchard JJ (2003) Neurocognitive, social, and emotional dysfunction in deficit syndrome schizophrenia. Schizophr Res 65:125–137PubMedCrossRef
35.
Zurück zum Zitat Milev P, Ho BC, Arndt S, Andreasen NC (2005) Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry 162:495–506PubMedCrossRef Milev P, Ho BC, Arndt S, Andreasen NC (2005) Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry 162:495–506PubMedCrossRef
36.
Zurück zum Zitat Ojeda N, Pena J, Sanchez P, Elizagarate E, Ezcurra J (2008) Processing speed mediates the relationship between verbal memory, verbal fluency, and functional outcome in chronic schizophrenia. Schizophr Res 101:225–233PubMedCrossRef Ojeda N, Pena J, Sanchez P, Elizagarate E, Ezcurra J (2008) Processing speed mediates the relationship between verbal memory, verbal fluency, and functional outcome in chronic schizophrenia. Schizophr Res 101:225–233PubMedCrossRef
37.
Zurück zum Zitat Sanchez P, Ojeda N, Pena J, Elizagarate E, Yoller AB, Gutierrez M, Ezcurra J (2009) Predictors of longitudinal changes in schizophrenia: the role of processing speed. J Clin Psychiatry 70:888–896PubMedCrossRef Sanchez P, Ojeda N, Pena J, Elizagarate E, Yoller AB, Gutierrez M, Ezcurra J (2009) Predictors of longitudinal changes in schizophrenia: the role of processing speed. J Clin Psychiatry 70:888–896PubMedCrossRef
38.
Zurück zum Zitat Bell M, Tsang HW, Greig TC, Bryson GJ (2009) Neurocognition, social cognition, perceived social discomfort, and vocational outcomes in schizophrenia. Schizophr Bull 35:738–747PubMedCrossRef Bell M, Tsang HW, Greig TC, Bryson GJ (2009) Neurocognition, social cognition, perceived social discomfort, and vocational outcomes in schizophrenia. Schizophr Bull 35:738–747PubMedCrossRef
39.
Zurück zum Zitat McDowd J, Tang TC, Tsai PC, Wang SY, Su CY (2011) The association between verbal memory, processing speed, negative symptoms and functional capacity in schizophrenia. Psychiatry Res 187:329–334PubMedCrossRef McDowd J, Tang TC, Tsai PC, Wang SY, Su CY (2011) The association between verbal memory, processing speed, negative symptoms and functional capacity in schizophrenia. Psychiatry Res 187:329–334PubMedCrossRef
40.
Zurück zum Zitat Moller HJ, Jager M, Riedel M, Obermeier M, Strauss A, Bottlender R (2010) The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity. Eur Arch Psychiatry Clin Neurosci 260:367–384PubMedCrossRef Moller HJ, Jager M, Riedel M, Obermeier M, Strauss A, Bottlender R (2010) The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity. Eur Arch Psychiatry Clin Neurosci 260:367–384PubMedCrossRef
41.
Zurück zum Zitat Strauss GP, Harrow M, Grossman LS, Rosen C (2010) Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study. Schizophr Bull 36:788–799PubMedCrossRef Strauss GP, Harrow M, Grossman LS, Rosen C (2010) Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study. Schizophr Bull 36:788–799PubMedCrossRef
42.
Zurück zum Zitat Hogarty GE, Flesher S, Ulrich R, Carter M, Greenwald D, Pogue-Geile M, Kechavan M, Cooley S, DiBarry AL, Garrett A, Parepally H, Zoretich R (2004) Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior. Arch Gen Psychiatry 61:866–876PubMedCrossRef Hogarty GE, Flesher S, Ulrich R, Carter M, Greenwald D, Pogue-Geile M, Kechavan M, Cooley S, DiBarry AL, Garrett A, Parepally H, Zoretich R (2004) Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior. Arch Gen Psychiatry 61:866–876PubMedCrossRef
43.
Zurück zum Zitat Eack SM, Hogarty GE, Cho RY, Prasad KM, Greenwald DP, Hogarty SS, Keshavan MS (2010) Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry 67:674–682PubMedCrossRef Eack SM, Hogarty GE, Cho RY, Prasad KM, Greenwald DP, Hogarty SS, Keshavan MS (2010) Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry 67:674–682PubMedCrossRef
44.
Zurück zum Zitat Fisher M, Holland C, Merzenich MM, Vinogradov S (2009) Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. Am J Psychiatry 166:805–811PubMedCrossRef Fisher M, Holland C, Merzenich MM, Vinogradov S (2009) Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. Am J Psychiatry 166:805–811PubMedCrossRef
Metadaten
Titel
General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia
verfasst von
János M. Réthelyi
Pál Czobor
Patrícia Polgár
Beatrix Mersich
Sára Bálint
Éva Jekkel
Krisztina Magyar
Ágnes Mészáros
Ágnes Fábián
István Bitter
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 2/2012
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-011-0224-4

Weitere Artikel der Ausgabe 2/2012

European Archives of Psychiatry and Clinical Neuroscience 2/2012 Zur Ausgabe

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.